drugset / Trial / NCT01503866

A Phase I Study to Investigate the Absorption, Metabolism and Excretion in Healthy Male Subjects

NCT01503866 ↗

Phase 1 Completed 6 enrolled Biogen
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to determine the absorption and excretion kinetics of bardoxolone methyl and to determine and characterize metabolites present in plasma, urine and feces in men following a single oral does or 20 mg of \[14C\]-bardoxolone methyl.

Timeline

Start
2011-12-01
Primary completion
2011-12-31
Completion
2011-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Bardoxolone methyl Small molecule 20 mg Oral

Indications

No indication recorded.